Duplication of 17q21 .qter is associated with a clinically recognizable syndrome. The major features are, profound mental retardation; dwartism; frontal bossing and temporal retraction, narrowing of the eyes; thln lips wlth overlapping of the lower lip by the upper lip; abnormal ears; cleft palate ' The region that appears to be respons~ble for the phenotype Is 17q23 .qterl Serothken et al, reported an infant mosaic for the duplication 17q21.1 -qter, their patient had many features suggestive of the 17q duplications syndrome except for the craniofacial dysmorphism3. We report an infant who was found to be mosaic for duplication 17q21 .qter who had none of the features associated wlth thls syndrome Our patient was the second child of a 24 year old mother and a 28 year old father. The pregnancy was complicated with an abnormal prenatal ultrasound that showed mild-moderate fetal ascites and mild pericardial effusion at 24 weeks gestation Genetic amniocentesis for karyotype analysis showed: 46,XX,dup (17) . At twelve months of age the patient's weight, length and head circumference were on the 50th percentile with normal development On examlnatlon she had, frontal bosslng; narrow palpebral fissures, flat nasal bridge; epicanthal folds; short nose; pointed chin; short neck, toe nail hypoplasla. Some of the above described facial features were also present in her parents. The family hlstory was negative for lymphedema Our patient IS the first reported case of dup 17q and dup 17q mosalclsm wlth lymphedema and essentially normal phenotype Cervical cancer is a malignancy which typically occurs at the transformation zone between squamous and glandular epithelium. The vast malorlty fall into two histologic types: squamous cell and adenocarcinoma.
We have previously reported extensively on abnormal chromosome 8 copy number i n varlous cancers, w h~c h appears to be an ubiquitous phenomenon.
I n the present pilot project, we studied chromosome 8 copy number together with a chromosome 17 control using formalin-fixed paraffin-embedded arch~val cervlcal cancer tissues. HER-2/neu oncogene amplification was also studied in this sample, as reported in a previous abstract presented at the 1998 Annual Meeting of the Amencan Society of Human Genetics. From a total of 23 cases successfully analyzed, 12 (52%) were found to be trisomic for chromosome 8, and 3 (13%) were found to be trisomic for chromosome 17. Of the trisomic 8 cases, 2 were also trisomic for chromosome 17, which implies that the tumors are either triploid or doubly trisomic. However 10 tumors were trisonuc for chromosome 8, but were dlsomic for chromosome 17. Among the 12 trisom~c 8 cases, 1 was also amplified for HER-2/neu whereas 11 were nonamplified. Cl~n~copathologic parameters of the trisomic and amplif~ed cases w~l l be compared to those of the disomic nonamplified cases. In view of the present results, further exploration using a larger study sample slze may be warranted. (This study was partially funded by Vysts, Inc., Downers Grove, IL).
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